In particular, our meta-analysis of 27 studies including 1545 NAFLD patients and 698 controls showed that circulating adiponectin levels were decreased in NAFLD patients compared with controls, and further decreased in NASH versus NAFL patients [66], which, in fact, followed the opposite direction compared to TNF-α [37]. This evidence concerns the gene TNF and metabolic dysfunction-associated steatohepatitis.